Kaempferol exemplifies multi-targeted efficacy: by downregulating ERK, JNK, and p38 expression, it suppresses MAPK signaling to reduce MMP-2/9 activation, thereby inhibiting adhesion, migration, and invasion in breast cancer MDA-MB-231 cells. This evidence concerns the gene MMP2 and breast carcinoma.